On this page
Neuro questions on the PCCN test what a progressive care nurse does at the bedside: score a stroke scale correctly, spot a reason not to give a drug, recognize a seizure emergency, and manage delirium without reaching for a sedative. The 13 questions below cover each of those.
There is no PCCN product page yet, so for preparation resources see our PCCN review course comparison and the PCCN study guide. Each keyed answer here rests on a named guideline, scale or FDA label, quoted in our source notes.
This set is exam practice written from the guidelines and FDA drug labels listed under References. The questions are original PrepSolution items, not AACN exam questions. It is not clinical guidance: follow your institution's protocols and the prescriber's orders. It has not been reviewed by a credentialed clinician.
Stroke assessment and treatment
Question 1: Scoring what you see
While scoring the NIH Stroke Scale, a nurse believes the patient could lift the left arm higher "if he really tried" and repeatedly urges him to try harder. What do the NIHSS instructions say?
- A. Score what the patient does, not what the clinician thinks the patient can do, and do not coach
- B. Coach the patient until the best effort is seen
- C. Average several attempts
- D. Skip the item and return to it later
Best answer: A. The NIHSS instructions say scores should reflect what the patient does, not what the clinician thinks the patient can do, and that, except where indicated, the patient should not be coached with repeated requests to make a special effort.
- B is not the best answer. Coaching is specifically ruled out except where an item allows it.
- C is not the best answer. The scale does not average attempts.
- D is not the best answer. The instructions say to work quickly and record answers as the exam is given, item by item.
Question 2: The first attempt counts
On item 1c (LOC commands), a patient is asked to open and close his eyes and grip and release his non-paretic hand. He does the eye task but not the grip; on a second request he does both. How is the item scored?
- A. 0, because he eventually did both
- B. 1, because only the first attempt is scored and he performed one task
- C. 2, because he needed two requests
- D. Not scored, because he needed repetition
Best answer: B. The NIHSS instructions for item 1c say only the first attempt is scored, and that performing one task correctly scores 1. His first attempt completed one of the two tasks.
- A is not the best answer. The second attempt is not scored.
- C is not the best answer. A score of 2 means neither task was performed correctly.
- D is not the best answer. The item is scored on the first attempt; it is not skipped.
Question 3: Testing gaze
For NIHSS item 2, Best Gaze, which eye movements are tested?
- A. Vertical eye movements only
- B. Both horizontal and vertical, with caloric testing
- C. Horizontal eye movements only
- D. Pupil reactivity to light
Best answer: C. The NIHSS instructions for Best Gaze say only horizontal eye movements are tested. Voluntary or reflexive (oculocephalic) movements are scored, and caloric testing is not done.
- A is not the best answer. Vertical movements are not tested on this item.
- B is not the best answer. Caloric testing is not done, and vertical gaze is not tested.
- D is not the best answer. Pupil reactivity is not part of the Best Gaze item.
Question 4: A reason not to give alteplase
A patient with acute ischemic stroke symptoms that began 90 minutes ago had a craniotomy for a meningioma 6 weeks ago. Under the Activase label, why is alteplase not given?
- A. Age over 65
- B. Stroke onset more than 1 hour ago
- C. A history of meningioma alone, regardless of timing
- D. Recent (within 3 months) intracranial surgery
Best answer: D. The label lists recent (within 3 months) intracranial or intraspinal surgery or serious head trauma among the situations in which alteplase should not be given for acute ischemic stroke, because the bleeding risk outweighs the benefit. Six weeks is within 3 months.
- A is not the best answer. Age is not a listed contraindication.
- B is not the best answer. The label directs treatment as soon as possible within 3 hours, and 90 minutes is inside that window.
- C is not the best answer. The listed contraindication is the recent surgery. The label separately lists intracranial conditions that may increase bleeding risk, but the 6-week-old craniotomy is the clear reason here.
Question 5: Blood pressure and alteplase
Which other finding does the Activase label list as a contraindication to treating acute ischemic stroke?
- A. Current severe uncontrolled hypertension
- B. Controlled hypertension on two medications
- C. Atrial fibrillation on aspirin
- D. A blood glucose of 180 mg/dL
Best answer: A. The label lists current severe uncontrolled hypertension among the situations in which the bleeding risk of alteplase is greater than the potential benefit in acute ischemic stroke.
- B is not the best answer. Controlled hypertension is not the listed contraindication.
- C is not the best answer. Neither atrial fibrillation nor aspirin use is on the label's list.
- D is not the best answer. This glucose is not a listed contraindication.
Question 6: Nimodipine course
A patient on a progressive care unit is recovering from aneurysmal subarachnoid hemorrhage and is taking oral nimodipine. For how long does the label direct the course?
- A. Until the patient is discharged
- B. 21 consecutive days
- C. 7 days
- D. Until headache resolves
Best answer: B. The nimodipine label gives the recommended oral regimen as a dose every 4 hours for 21 consecutive days, starting as soon as possible within 96 hours of SAH onset.
- A is not the best answer. Discharge does not end the labeled course.
- C is not the best answer. Seven days is shorter than the label's course.
- D is not the best answer. Symptom relief does not set the course length.
Question 7: A drug interaction
The same patient develops seizures, and phenytoin is being considered. What does the nimodipine label say about strong CYP3A4 inducers such as phenytoin?
- A. They raise nimodipine levels, so the dose must be halved.
- B. They have no effect on nimodipine.
- C. Concomitant use should generally be avoided because nimodipine levels and efficacy may be very significantly reduced.
- D. They are preferred because they prevent vasospasm.
Best answer: C. The label warns that strong CYP3A4 inducers, naming phenytoin among them, should generally be avoided with nimodipine because nimodipine plasma concentration and efficacy may be very significantly reduced. The prescriber needs to know before the anticonvulsant is chosen.
- A is not the best answer. Inducers lower nimodipine levels, not raise them.
- B is not the best answer. The label describes a very significant interaction.
- D is not the best answer. The label gives no such benefit; the concern is lost nimodipine effect.
Seizures
Question 8: Why the first drug matters
A nurse is preparing a seizure response plan for the unit. What did the American Epilepsy Society find about response to successive therapies for status epilepticus in adults?
- A. Each therapy is equally effective, so order does not matter.
- B. The third therapy is the most effective.
- C. Only the second therapy has evidence in adults.
- D. The second therapy is less effective than the first, and the third is substantially less effective.
Best answer: D. The guideline reports (Level A) that in adults, compared with the first therapy, the second therapy is less effective and the third therapy is substantially less effective. Giving an adequate first-line benzodiazepine promptly matters.
- A is not the best answer. The guideline found declining effectiveness with each line.
- B is not the best answer. The third therapy is the least effective of the three.
- C is not the best answer. The guideline reports on first, second and third therapies in adults.
Question 9: When fosphenytoin replaces oral phenytoin
A patient on oral phenytoin for epilepsy is made NPO for a procedure. Per the Cerebyx label, when can fosphenytoin be substituted?
- A. Whenever the patient prefers IV therapy
- B. Short-term, only when oral phenytoin administration is not possible
- C. Permanently, as a replacement for oral phenytoin
- D. Never; it is only for status epilepticus
Best answer: B. The label says Cerebyx can be substituted, short-term, for oral phenytoin and should be used only when oral phenytoin administration is not possible. It is also indicated for generalized tonic-clonic status epilepticus and seizures during neurosurgery.
- A is not the best answer. Preference is not the label's criterion.
- C is not the best answer. The label limits the substitution to short-term use.
- D is not the best answer. The label lists substitution for oral phenytoin as an indication in addition to status epilepticus.
Delirium
Question 10: Preventing and reducing delirium
A 79-year-old transferred from the ICU has been intermittently confused at night. Which approach matches SCCM's PADIS guideline for delirium in critically ill adults?
- A. A multicomponent nonpharmacologic program addressing modifiable risk factors, cognition, sleep, mobility, hearing and vision
- B. Scheduled haloperidol every night
- C. Bright light therapy at night
- D. Physical restraints to prevent falls
Best answer: A. PADIS suggests a multicomponent, nonpharmacologic intervention focused on reducing modifiable risk factors for delirium, improving cognition, and optimizing sleep, mobility, hearing and vision.
- B is not the best answer. PADIS suggests not routinely using haloperidol or atypical antipsychotics to treat delirium.
- C is not the best answer. PADIS suggests not using bright light therapy to reduce delirium.
- D is not the best answer. Restraints are not part of the PADIS delirium recommendation.
Question 11: Subsyndromal delirium
A patient has some features of delirium but does not meet full criteria. The team asks about starting haloperidol. What does PADIS suggest?
- A. Start haloperidol to prevent progression
- B. Start an atypical antipsychotic instead of haloperidol
- C. Start a benzodiazepine at night
- D. Not using haloperidol or an atypical antipsychotic to treat subsyndromal delirium
Best answer: D. PADIS suggests not using haloperidol or an atypical antipsychotic to treat subsyndromal delirium in critically ill adults.
- A is not the best answer. PADIS suggests against this use.
- B is not the best answer. The suggestion covers atypical antipsychotics too.
- C is not the best answer. Benzodiazepines are not part of PADIS delirium management, and PADIS prefers non-benzodiazepine sedatives when sedation is needed.
Traumatic brain injury
Question 12: Blood pressure without an ICP monitor
A patient with a moderate TBI is admitted to a progressive care bed with no ICP monitor. Which blood pressure target does the ACS TQIP guideline give for adequate cerebral perfusion in most cases?
- A. SBP at least 90 mm Hg
- B. SBP under 100 mm Hg
- C. SBP at least 110 mm Hg and MAP above 80 mm Hg
- D. MAP above 120 mm Hg
Best answer: C. The TQIP guideline says treatment targeting an SBP of at least 110 mm Hg and a MAP above 80 mm Hg will allow adequate cerebral perfusion in most cases when ICP is not being monitored, and calls these ideal ranges rather than mandatory goals.
- A is not the best answer. This is lower than the TQIP target.
- B is not the best answer. Lowering pressure risks hypoperfusion of injured brain.
- D is not the best answer. This is far above the TQIP target.
Question 13: Positioning after TBI
Which head-of-bed position does the ACS TQIP guideline list for patients with severe TBI?
- A. Flat
- B. 30 to 45 degrees
- C. 10 degrees
- D. Trendelenburg
Best answer: B. The TQIP guideline lists elevating the head of the bed to 30 to 45 degrees among the expected interventions for severe TBI.
- A is not the best answer. Flat positioning is not what the guideline lists.
- C is not the best answer. Ten degrees is below the listed range.
- D is not the best answer. Head-down positioning would oppose venous drainage from the head.
Where does neuro sit on the PCCN?
The PCCN Exam Handbook lists neurology as 7% of the test plan, within a combined section for endocrine, hematology, neurology, gastrointestinal and renal topics. Its testable nursing actions for neurology include using the NIH Stroke Scale, bedside dysphagia screening, managing EEG monitoring and managing neuro tubes and drains. The exam has 150 items, 125 of them scored.
NIHSS rules worth memorizing
| Rule | What it means at the bedside |
|---|---|
| Score what the patient does | Not what you think the patient could do |
| Do not coach | No repeated requests for a special effort, except where an item allows it |
| 1a when the exam is limited | You must still choose a response if an endotracheal tube or language barrier limits the exam |
| 1c commands | Only the first attempt is scored |
| 2 Best gaze | Horizontal movements only; no caloric testing |
How should you use this set?
Answer each question before reading the rationale. For stroke items, decide what the scale or label says before you weigh the clinical story. For more PCCN practice, work the PCCN multisystem questions and PCCN cardiovascular questions.
References
- [1] AACN Certification Corporation (2026). PCCN Exam Handbook, Direct Care (July 2026). AACN Certification Corporation. AACN Certification Corporation
- [2] NINDS (2026). NIH Stroke Scale. NINDS. NINDS
- [3] FDA label (2026). Activase (alteplase). FDA label. FDA label
- [4] American Epilepsy Society (2016). Evidence-Based Guideline, Treatment of Convulsive Status Epilepticus in Children and Adults. American Epilepsy Society. American Epilepsy Society
- [5] FDA label (2026). Cerebyx (fosphenytoin sodium) injection. FDA label. FDA label
- [6] FDA label (2026). Nimodipine capsules. FDA label. FDA label
- [7] Society of Critical Care Medicine (2018). PADIS Guidelines (Pain, Agitation/Sedation, Delirium, Immobility, Sleep). Society of Critical Care Medicine. Society of Critical Care Medicine
- [8] American College of Surgeons TQIP (2026). Best Practices Guidelines, The Management of Traumatic Brain Injury. American College of Surgeons TQIP. American College of Surgeons TQIP
Help us improve this guide
How helpful was this article?
One tap helps us understand what’s useful.
Frequently asked questions
The PCCN test plan lists neurology at 7%, covering encephalopathy, seizures, stroke, TBI, space-occupying lesions, altered mental status, delirium and dementia.
Yes. Using the NIHSS is listed among the PCCN testable nursing actions for neurology.
No, except where an item indicates otherwise. The instructions say to score what the patient does and not to coach.
A multicomponent nonpharmacologic program, and not using haloperidol or atypical antipsychotics to treat subsyndromal delirium.
Not yet. See the PCCN review course comparison and the PCCN study guide for preparation resources.
No. They are original PrepSolution practice items written from the guidelines, scale instructions and FDA labels listed under References. They have not been reviewed by a credentialed clinician and are not clinical guidance.
Choose your next study resource.
Find practice questions and study materials for your exam.
Related Articles
PCCN Cardiovascular Practice: Hemodynamics and Deterioration
Cardiovascular content makes up 20% of the Adult PCCN exam — the largest clinical category. These original progressive-care cases cover MAP calculation, stable versus unstable tachyarrhythmia response, heart-failure decompensation, ACS priorities, post-cath complications, and beta-blocker hold parameters.
PCCN Multisystem Practice: Sepsis, Renal, and Endocrine Cases
Original PCCN-style practice cases in sepsis escalation, renal injury and potassium safety, and endocrine emergencies. Each case includes rationale and explicitly flags where facility protocols govern specifics.
PCCN Study Guide: Current Test Plan and Preparation Steps
The Adult PCCN exam is 150 items (125 scored, 25 unscored) over 3 hours under the test plan effective February 6, 2024. AACN reports a 70.10% first-time pass rate for 2025. Here is how progressive-care nurses should map their review and build a first diagnostic.
